4//SEC Filing
NAGER NANCY 4
Accession 0001178913-10-000279
CIK 0000793279other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:30 PM ET
Size
12.1 KB
Accession
0001178913-10-000279
Insider Transaction Report
Form 4
NAGER NANCY
Director
Transactions
- Disposition to Issuer
Common Stock
2010-01-05−2,000→ 0 total - Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−40,000→ 0 totalExercise: $4.29Exp: 2018-01-25→ Common Stock, $0.01 par value per share (40,000 underlying) - Disposition to Issuer
Stock Appreciation Rights (right to buy)
2010-01-05−30,000→ 0 totalExercise: $15.33Exp: 2016-01-30→ Common Stock, $0.01 par value per share (30,000 underlying) - Disposition to Issuer
Non Qualified Stock Option (right to buy)
2010-01-05−15,000→ 0 totalExercise: $9.50Exp: 2015-02-11→ Common Stock, $0.01 par value per share (15,000 underlying)
Footnotes (4)
- [F1]These shares were disposed of pursuant to a merger agreement between the Issuer and Syneron Medical Ltd. ("Syneron") in exchange for 582 ordinary shares of Syneron having a market value of $10.39 per share at the close of trading on the effective date of the merger.
- [F2]The stock-settled stock appreciation rights, which were exercisable in two equal installments beginning on January 19, 2009, were cancelled by Candela.
- [F3]The stock-settled stock appreciation rights, which were exercisable in two installments beginning on January 30, 2007, were cancelled by Candela.
- [F4]The non-qualified stock options, which were exercisable in one installment beginning on February 11, 2005, were cancelled by Candela.
Documents
Issuer
CANDELA CORP /DE/
CIK 0000793279
Entity typeother
Related Parties
1- filerCIK 0001216077
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:30 PM ET
- Size
- 12.1 KB